{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-005435","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2023-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.226107+00:00","generated_at":"2026-06-19T08:07:34.730705+00:00","sec_items":["2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AgeX Therapeutics draws $1M under amended convertible note with Juvenescence; issues warrants for 801,924 shares","bullets":["On Feb 15, 2023, drew $1M under Amended Secured Convertible Note with Juvenescence Limited.","Up to $2M additional available until May 9, 2023; each draw limited to $1M and subject to Juvenescence's approval.","Warrants for 801,924 shares at exercise price of $0.6235 per share issued in connection with the draw.","Repayment date unchanged at Feb 14, 2024; note secured by security interests in AgeX assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-005435","json":"https://secwatch.observer/filing/0001493152-23-005435.json","markdown":"https://secwatch.observer/filing/0001493152-23-005435.md","text":"https://secwatch.observer/filing/0001493152-23-005435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/0001493152-23-005435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T08:07:34.730705+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"75f67463f7000c1a24b1bec5e208e5f625b2c4dc","claim":"Serina Therapeutics, Inc. incurred senior notes of $1 million with Juvenescence Limited maturing February 14, 2024.","evidence_excerpt":"On February 15, 2023, AgeX drew $1 million of its available credit under the Amended and Restated Secured Convertible Promissory Note (“Amended Note”) dated February 9, 2023 with Juvenescence Limited (“Juvenescence”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/0001493152-23-005435-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$1 million"},{"label":"Counterparty","value":"Juvenescence Limited"},{"label":"Maturity","value":"February 14, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}